Cargando…

Health-related quality-of-life and treatment satisfaction of individuals with hemophilia A treated with turoctocog alfa pegol (N8-GP): a new recombinant extended half-life FVIII

BACKGROUND: Prophylactic treatment regimens lead to improvements in health-related quality-of-life (HRQoL) among individuals with hemophilia. Turoctocog alfa pegol (N8-GP) provides the benefit of extending the duration of protection from bleeding and reducing the number of injections, which is expec...

Descripción completa

Detalles Bibliográficos
Autores principales: Kearney, Susan, Raffini, Leslie J, Pham, Tan P, Lee, Xin Ying, von Mackensen, Sylvia, Landorph, Andrea, Takedani, Hideyuki, Oldenburg, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460998/
https://www.ncbi.nlm.nih.gov/pubmed/31040652
http://dx.doi.org/10.2147/PPA.S196103